GE

Gregory William Endres

CC Cayman Chemical Company: 20 patents #1 of 39Top 3%
University of Michigan: 1 patents #1,906 of 4,352Top 45%
📍 Saline, MI: #22 of 509 inventorsTop 5%
🗺 Michigan: #3,523 of 86,293 inventorsTop 5%
Overall (All Time): #191,208 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Showing 1–22 of 22 patents

Patent #TitleCo-InventorsDate
12019002 Ready-to-extract platforms for chemical analysis and quantification of unknown samples using spiked matrix standards Jeffery Moran 2024-06-25
11884624 Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Bradlee David Germain, Andriy Kornilov +3 more 2024-01-30
11066361 Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Bradlee David Germain, Andriy Kornilov +3 more 2021-07-20
10729810 Methods, systems, and compositions for promoting bone growth Stephen Douglas Barrett, Joseph Michael Colombo, Bradlee David Germain, Andriy Kornilov, James Bernard Kramer +4 more 2020-08-04
10556862 Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Bradlee David Germain, Andriy Komilov +3 more 2020-02-11
10450257 Methods of synthesizing a prostacyclin analog Kirk William Hering, Gilles Chambournier, Victor Fedij, Thomas James Krell, II, Hussein Mahmoud Mahmoud 2019-10-22
10155716 Amine salts of a prostacyclin analog Gilles Chambournier, Kirk William Hering, Victor Fedij, Hussein Mahmoud Mahmoud 2018-12-18
9908834 Methods of synthesizing a prostacyclin analog Kirk William Hering, Gilles Chambournier, Victor Fedij, Thomas James Krell, II, Hussein Mahmoud Mahmoud 2018-03-06
9890104 Amine salts of a prostacyclin analog Gilles Chambournier, Kirk William Hering, Victor Fedij, Hussein Mahmoud Mahmoud 2018-02-13
9701630 Difluorolactam compositions for EP4-mediated osteo related diseases and conditions Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Bradlee David Germain, Andriy Kornilov +4 more 2017-07-11
9688627 Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions Stephen Douglas Barrett, Joseph Michael Colombo, Bradlee David Germain, Andriy Komilov, James Bernard Kramer +5 more 2017-06-27
9676712 Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions Stephen Douglas Barrett, Bradlee David Germain, Adam Uzieblo, Fred Lawrence Ciske, Andriy Kornilov +3 more 2017-06-13
9487478 Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Bradlee David Germain, Andriy Kornilov +3 more 2016-11-08
9440919 Difluorolactam compositions for EP4-mediated osteo related diseases and conditions Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Bradlee David Germain, Andriy Kornilov +4 more 2016-09-13
9180116 Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Bradlee David Germain, Andriy Kornilov +3 more 2015-11-10
9126973 Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases Pil Heui Lee, Kirk L. Olson, James Bernard Kramer, Fred Lawrence Ciske, Stephen Douglas Barrett 2015-09-08
9120820 Fluorescent molecular probes for use in assays that measure test compound competitive binding with SAM-utilizing proteins Stephen Douglas Barrett, Daniel Austin Bochar, Levi BLAZER, Fred Lawrence Ciske, Jeffrey Keith Johnson +4 more 2015-09-01
8680327 Methods for manufacturing tetranor-prostaglandin D, J, E, A and F metabolites Andriy Kornilov, Adam Uzieblo 2014-03-25
8536185 Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases Pil Heui Lee, Kirk L. Olson, James Bernard Kramer, Fred Lawrence Ciske, Stephen Douglas Barrett 2013-09-17
8440417 Method for assaying compounds or agents for ability to displace potent ligands of hematopoietic prostaglandin D synthase Nisha Palackal, Jeffrey Keith Johnson, Karie L. McGowan, Kirk W. Maxey 2013-05-14
8063240 Prostaglandin E1 and E2 analogs for the treatment of various medical conditions Nancy Barta, Stephen Douglas Barrett, Andriy Kornilov, Kirk M. Maxey, Adam Uzieblo 2011-11-22
6410622 Method of preventing fouling organisms in marine environments and polymer-bound nitric oxide/nitric oxide-releasing compositions usable therefor 2002-06-25